Sjögren-szindróma: vizsgálatok itt: Franciaország
20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Angers, Blois Cedex, Bordeaux, Brest, Caen, Dijon, La Roche Sur Yon Cedex 9, Le Kremlin-Bicetre, Le Mans Cedex 9, Lille, Montpellier Cedex 5, Paris Cedex 13, Saint-Etienne, Strasbourg Cedex 2, Toulon Cedex 9, Valenciennes, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - 2. fázisTaking peopleA Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
- Where
- Brest, Caen, Le Mans Cedex 9, Paris, Saint-Priest-en-Jarez, Strasbourg Cedex 2
- Életkor
- 18 év to 100 év
- People
- 344 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00 - No phaseTaking peopleEvaluation of the Prevalence, and Immunological Characteristics of Small Fiber Neuropathy in Patients With Primary Sjögren's Syndrome
- Where
- Amiens
- Életkor
- 18 év and over
- People
- 100
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07917442 - 3. fázisTaking peoplePhase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Where
- Angers, Bordeaux, Brest, Caen, Colmar Cedex, Le Kremlin-Bicetre, Paris Cedex 13, St Etienne Cedex 2, Strasbourg Cedex 2
- Életkor
- 18 év to 75 év
- People
- 250 worldwide
- Run by
- Vor Biopharma
See details and how to joinNCT07404865 · EU 2026-525556-28-00 - 1. fázisNot yet taking people in FranciaországA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Montpellier, Paris
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - No phaseNot yet taking people in FranciaországExploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's Syndrome
- Where
- Dijon
- Életkor
- 18 év and over
- People
- 20
- Run by
- Centre Hospitalier Universitaire Dijon
See details and how to joinNCT07861828 - No phaseTaking peopleFatigue in Sjögren's Syndrome: 3 Therapeutic Strategies
- Where
- Saint-Etienne
- Életkor
- 18 év and over
- People
- 174
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT06875102 - 2. fázisNot yet taking people in FranciaországA Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
- Where
- Bordeaux, Paris, Paris Cedex 10, Saint-Priest-en-Jarez, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- argenx
See details and how to joinNCT07760818 · EU 2026-526218-10-00 - 1. fázisTaking peopleA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- Where
- Brest, Le Kremlin-Bicêtre, Nantes, Saint Priest En Jarez, Strasbourg
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT07041099 - 1. fázisTaking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Where
- Montpellier, Strasbourg Cedex 2
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00 - 2. fázisTaking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Marseille, Montpellier, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - No phaseTaking peopleB-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
- Where
- Brest
- Életkor
- 18 év and over
- People
- 1000
- Run by
- University Hospital, Brest
See details and how to joinNCT04931160 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Bordeaux, Toulouse Cedex 9
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - 1. fázisTaking peopleA Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease
- Where
- Brest, Le Kremlin-Bicetre, Nantes, Saint-Priest-en-Jarez, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to join2025-521462-96-00 · EU 2025-521462-96-00 - No phaseTaking peopleAutoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
- Where
- Bourgoin, Clermont-Ferrand, Grenoble, Lyon, Reims, Saint-Etienne
- Életkor
- 18 év and over
- People
- 185
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT03003572 - 3. fázisTaking peopleA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Bordeaux, Brest, Le Kremlin Bicetre Cedex, Mulhouse, Paris, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00 - No phaseTaking peopleEffects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Where
- Orléans
- Életkor
- 18 év and over
- People
- 100
- Run by
- Centre Hospitalier Régional d'Orléans
See details and how to joinNCT06842316 - No phaseTaking peopleAssessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 352
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT05927688 - No phaseTaking peopleDental and Periodontal Status of Patients With Sjögren's Syndrome.
- Where
- Ivry-sur-Seine
- Életkor
- 18 év and over
- People
- 100
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04848870 - No phaseNot yet taking people in FranciaországUltrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
- Where
- Brest
- People
- 501
- Run by
- University Hospital, Brest
See details and how to joinNCT06680310